Market cap
₹30 Cr
Recently Viewed
Clear AllMarket cap
₹30 Cr
Revenue (TTM)
₹1 Cr
P/E Ratio
350
P/B Ratio
3.1
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹0 Cr
ROE
2.2 %
ROCE
3 %
Industry P/E
22.77
EV/EBITDA
138.7
Debt to Equity
0
Book Value
₹9.5
EPS
₹0.1
Face value
10
Shares outstanding
10,084,800
CFO
₹-0.16 Cr
EBITDA
₹0.02 Cr
Net Profit
₹0.16 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Omkar Pharmachem
| -- | -- | -- | -- | -- | -- | -- |
|
BSE Commodities
| 3.7 | 9.2 | 0.8 | 18.6 | 17.1 | 13.0 | 16.0 |
|
Company
|
2020
|
|---|---|
|
Omkar Pharmachem
| 17.4 |
|
BSE Small Cap
| 32.1 |
|
BSE Commodities
| 26.1 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Omkar Pharmachem
|
29.5 | 29.8 | 0.5 | 0.1 | 40.2 | 0.9 | 350 | 3.1 |
| 1,404.7 | 7,174.2 | 1,535.0 | 180.7 | 13.7 | 12.7 | 39.7 | 4.8 | |
| 3,669.9 | 15,879.1 | 15,069.6 | 378.2 | 3.0 | 9.9 | 42 | 4.1 | |
| 1,212.2 | 15,378.1 | 11,162.0 | 877.2 | 12.4 | 13.7 | 17.6 | 2.3 | |
| 1,203.3 | 5,194.0 | 2,418.7 | 337.7 | 17.0 | 16.9 | 15.4 | 2.4 | |
| 1,797.8 | 6,395.0 | 5,078.5 | 280.8 | 7.1 | 11.9 | 22.8 | 2.5 | |
| 2,499.7 | 8,021.7 | 15,622.2 | 1,787.5 | 16.6 | 12.6 | 8.9 | 1.0 | |
| 4,704.7 | 6,402.2 | 1,886.6 | 168.0 | 11.4 | 16.6 | 38.1 | 4.8 | |
| 6,222.5 | 31,911.2 | 3,077.1 | 545.9 | 25.9 | 18 | 58.5 | 8.4 | |
| 719.3 | 18,339.9 | 14,655.0 | 194.0 | 4.8 | 1.2 | 101.9 | 0.8 |
No Review & Analysis are available.
Manufacture of pharmaceuticals, medicinal chemical and botanical products
Incorporated
1995
Chairman
--
Managing Director
Bhawani Shankar Goyal
Headquarters
Ahmedabad, Gujarat
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Omkar Pharmachem Ltd is ₹29.50 (BSE) as of 15-Apr-2026 IST. Omkar Pharmachem Ltd has given a return of --% in the last 1 years.
The P/E ratio of Omkar Pharmachem Ltd is 350.00 times as on 15-Apr-2026, a 1437 premium to its peers’ median range of 22.77 times.
The P/B ratio of Omkar Pharmachem Ltd is 3.12 times as on 15-Apr-2026, a 99 premium to its peers’ median range of 1.57 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.00
|
|
2024
|
119.87
|
2.46
|
|
2023
|
127.42
|
2.79
|
|
2022
|
112.33
|
2.33
|
|
2021
|
0.00
|
0.00
|
The 52-week high and low of Omkar Pharmachem Ltd are Rs 30.09 and Rs 25.50 as of 16-Apr-2026.
Omkar Pharmachem Ltd has a market capitalisation of ₹ 30 Cr as on 15-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Omkar Pharmachem Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.